[Chemotherapy of Campylobacter infections].

Abstract

A total of 600 patients with suspected alimentary food poisoning were hospitalized. The ++clinico-laboratory findings showed that 27 (4.5 per cent) of them had Campylobacter infection. The cultures of Campylobacter jejuni and Campylobacter coli were isolated from 24 and 3 patients, respectively. The patients underwent complex pathogenetic treatment with oral rehydration saline solutions, symptomatic agents, enzymatic preparations and diet (the basic therapy) supplemented with biological bacterial preparations in less severe cases (8 patients). Antibacterial drugs such as furazolidone (roxytromycin), gentamicin and levomycetin, as well as fluoroquinolones such as ofloxacin and ciprofloxacin were additionally used in the treatment of both the patients with the generalized infection and those with more severe processes of the disease, pronounced diarrhea with blood traces and persisting isolation of Campylobacter (12 patients). The most favourable results in the treatment of more severe patients with Campylobacter infection were obtained with the fluoroquinolones used after inadequately efficient therapy with furazolidone or antibiotics especially in the cases with repeated isolation of campylobacteria.

• Authors: N M Gracheva, O S Partin, I T Shcherbakov, V I Ivanova, S N Fokin
• Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (Antibiot Khimioter) Vol. 37 Issue 6 Pg. 31-5 (Jun 1992) ISSN: 0235-2990 [Print] Russia (Federation)
• Vernacular Title: Khimioterapiia kampilobakterioza.
• PMID: 1417342 (Publication Type: Case Reports, Comparative Study, Journal Article)

Chemical References

• Ciprofloxacin

Topics

• Adult
• Age Factors
• Campylobacter Infections (diagnosis, drug therapy)
• Campylobacter coli (drug effects, isolation & purification)
• Campylobacter jejuni (drug effects, isolation & purification)
• Ciprofloxacin (therapeutic use)
• Enterocolitis (diagnosis, drug therapy)
• Female
• Gastroenteritis (diagnosis, drug therapy)
• Humans
• Male
• Middle Aged
• Remission Induction
• Severity of Illness Index